REQUEST A DEMO
Total
USD $0.00
Search more companies

Abcam Singapore Pte. Ltd. (Singapore)

Main Activities: Research and Development in Biotechnology (except Nanobiotechnology)
Secondary Activities: Other Chemical and Allied Products Merchant Wholesalers
Full name: Abcam Singapore Pte. Ltd. Profile Updated: March 29, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Primary Business Activity: research and experimental development on medical science (import of protein research tools for life science researchers); Secondary Business Activity: wholesale of chemicals and chemical products n.e.c. (sale of protein research tools for life science researchers)

Headquarters
11 North Buona Vista Drive, #16-08 The Metropolis, Singapore
Singapore; Singapore; Postal Code: 138589

Contact Details: Purchase the Abcam Singapore Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Abcam Singapore Pte. Ltd. report to view the information.
Outstanding Shares:
Purchase the Abcam Singapore Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Abcam Singapore Pte. Ltd. report to view the information.
Incorporation Date:
July 01, 2015
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Company Secretary
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Abcam Singapore Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
947.28%
Total operating revenue
947.28%
Net Profit (Loss) for the Period
11645.45%
Total assets
786.61%
Total equity
460.28%
Net Profit Margin
6.49%
Return on Equity (ROE)
88.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?